227 related articles for article (PubMed ID: 31030017)
1. The relationship between cognitive function and body mass index in multiple sclerosis patients.
Owji M; Ashraf-Ganjouei A; Sahraian MA; Bidadian M; Ghadiri F; Naser Moghadasi A
Mult Scler Relat Disord; 2019 Jul; 32():37-40. PubMed ID: 31030017
[TBL] [Abstract][Full Text] [Related]
2. The Italian validation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) and the application of the Cognitive Impairment Index scoring procedure in MS patients.
Argento O; Incerti CC; Quartuccio ME; Magistrale G; Francia A; Caltagirone C; Pisani V; Nocentini U
Neurol Sci; 2018 Jul; 39(7):1237-1244. PubMed ID: 29704074
[TBL] [Abstract][Full Text] [Related]
3. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
López-Góngora M; Querol L; Escartín A
BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
[TBL] [Abstract][Full Text] [Related]
4. The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients.
Noori H; Gheini MR; Rezaeimanesh N; Saeedi R; Rezaei Aliabadi H; Sahraian MA; Naser Moghadasi A
Mult Scler Relat Disord; 2019 Nov; 36():101415. PubMed ID: 31586799
[TBL] [Abstract][Full Text] [Related]
5. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.
Kabiri S; Jameie M; Balali P; Adib Moradi S; Sanjari Moghaddam H; Aghamollaii V; Harirchian MH
Arch Clin Neuropsychol; 2023 Jan; 38(1):37-48. PubMed ID: 35901460
[TBL] [Abstract][Full Text] [Related]
6. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
7. Altered individual behavioral and EEG parameters are related to the EDSS score in relapsing-remitting multiple sclerosis patients.
Vázquez-Marrufo M; Galvao-Carmona A; Caballero-Díaz R; Borges M; Paramo MD; Benítez-Lugo ML; Ruiz-Peña JL; Izquierdo G
PLoS One; 2019; 14(7):e0219594. PubMed ID: 31306457
[TBL] [Abstract][Full Text] [Related]
8. Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
Maubeuge N; Deloire MSA; Brochet B; Ehrlé N; Charré-Morin J; Saubusse A; Ruet A;
Mult Scler Relat Disord; 2021 Feb; 48():102692. PubMed ID: 33352358
[TBL] [Abstract][Full Text] [Related]
9. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Guy's Neurological Disability Scale as a screening tool for cognitive impairment in multiple sclerosis.
Akatani R; Chihara N; Tachibana H; Koto S; Kowa H; Kanda F; Matsumoto R; Toda T
Mult Scler Relat Disord; 2019 Oct; 35():272-275. PubMed ID: 31442905
[TBL] [Abstract][Full Text] [Related]
11. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
Niccolai C; Portaccio E; Goretti B; Hakiki B; Giannini M; Pastò L; Righini I; Falautano M; Minacapelli E; Martinelli V; Incerti C; Nocentini U; Fenu G; Cocco E; Marrosu MG; Garofalo E; Ambra FI; Maddestra M; Consalvo M; Viterbo RG; Trojano M; Losignore NA; Zimatore GB; Pietrolongo E; Lugaresi A; Pippolo L; Roscio M; Ghezzi A; Castellano D; Stecchi S; Amato MP
BMC Neurol; 2015 Oct; 15():204. PubMed ID: 26472052
[TBL] [Abstract][Full Text] [Related]
13. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
[TBL] [Abstract][Full Text] [Related]
14. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
15. The symbol digit modalities test and the paced auditory serial addition test involve more than processing speed.
Berrigan LI; LeFevre JA; Rees LM; Berard JA; Francis A; Freedman MS; Walker LAS
Mult Scler Relat Disord; 2022 Dec; 68():104229. PubMed ID: 36279599
[TBL] [Abstract][Full Text] [Related]
16. What is the meaning of PASAT rejection in multiple sclerosis?
Cortés-Martínez A; Matias-Guiu JA; Pytel V; Montero P; Moreno-Ramos T; Matías-Guiu J
Acta Neurol Scand; 2019 Jun; 139(6):559-562. PubMed ID: 30908588
[TBL] [Abstract][Full Text] [Related]
17. [Information processing speed and influential factors in multiple sclerosis].
Zhang ML; Xu EH; Dong HQ; Zhang JW
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
[TBL] [Abstract][Full Text] [Related]
18. Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
Lozano-Soto E; Cruz-López ÁJ; Gutiérrez R; González M; Sanmartino F; Rashid-Lopez R; Espinosa-Rosso R; Forero L; González-Rosa JJ
Arch Clin Neuropsychol; 2021 May; 36(4):475-484. PubMed ID: 33067616
[TBL] [Abstract][Full Text] [Related]
19. Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis.
Kizlaitienė R; Kaubrys G; Giedraitienė N; Ramanauskas N; Dementavičienė J
Med Sci Monit; 2017 Feb; 23():588-597. PubMed ID: 28145395
[TBL] [Abstract][Full Text] [Related]
20. The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis.
Siepman TA; Janssens AC; de Koning I; Polman CH; Boringa JB; Hintzen RQ
J Neurol; 2008 Jun; 255(6):910-6. PubMed ID: 18484237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
